XLVIvsETF 2ETF Comparison
ETF 1
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.17%
VS
Choose a second ETF to run a side-by-side ETF comparison with XLVI, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLVI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/22/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI ETF 2 | +3.88%– | +7.81%– | +5.20%– | n/a– | n/a– | n/a– |
| Flows | XLVI ETF 2 | +$2M– | +$5M– | +$7M– | -– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI ETF 2 | +12.38%– | n/a– | n/a– | n/a– |
| Max drawdown | XLVI ETF 2 | -2.06%– | n/a– | n/a– | n/a– |
| Max drawdown duration | XLVI ETF 2 | 7d– | n/a– | n/a– | n/a– |
Trading data
XLVI | ETF 2 | |
Last sale 7/24/2026 at 1:30 PM | $26.52 | – |
| Previous close 07/23/2026 | $26.33 | – |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
XLVI | ETF 2 | |
|---|---|---|
| Last price | $26.52 | – |
| 1D performance | +0.72% | – |
| AuM | $18.27 M | – |
| E/R | 0.35% | – |
Characteristics
XLVI | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | State Street Investment Management | – |
| Benchmark | - | – |
| N° of holdings | 59 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | July 30, 2025 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
XLVI
USA
100.53%
Other
-0.53%
ETF 2
Sectors
XLVI
Healthcare
100.33%
Other
-0.33%
ETF 2
Advertisement
Diversification
XLVI
Total weight of top 15 holdings out of 15
74.76%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
XLVI
Eli Lilly & Co.
17.01%
Johnson & Johnson
10.96%
AbbVie, Inc.
7.97%
UnitedHealth Group, Inc.
6.77%
Merck & Co., Inc.
5.69%
Amgen, Inc.
3.50%
Thermo Fisher Scientific, Inc.
3.34%
Abbott Laboratories
2.83%
Gilead Sciences, Inc.
2.81%
Intuitive Surgical, Inc.
2.53%
Pfizer Inc.
2.46%
CVS Health Corp.
2.37%
Vertex Pharmaceuticals, Inc.
2.26%
Danaher Corp.
2.15%
Bristol Myers Squibb Co.
2.11%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
